EDGAR Filing Documents for 0001193125-18-150803

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-18-150803

Filing Date

2018-05-03

Accepted

2018-05-03 16:08:12

Documents

Period of Report

2018-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	d331981d10q.htm	10-Q	985008
2	EX-31.1	d331981dex311.htm	EX-31.1	9863
3	EX-31.2	d331981dex312.htm	EX-31.2	9871
4	EX-32	d331981dex32.htm	EX-32	4821
	Complete submission text file	0001193125-18-150803.txt		7358202

Data Files

Seq	Description	Document	Type	Size
5	XBRL INSTANCE DOCUMENT	teva-20180331.xml	EX-101.INS	1540539
6	XBRL TAXONOMY EXTENSION SCHEMA	teva-20180331.xsd	EX-101.SCH	92514
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	teva-20180331_cal.xml	EX-101.CAL	99672
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	teva-20180331_def.xml	EX-101.DEF	474280
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE	teva-20180331_lab.xml	EX-101.LAB	595690
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	teva-20180331_pre.xml	EX-101.PRE	555813

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)